Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4108)
All Articles published online
|
Nov 26, 2011 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun XY, Nong J, Qin K, Warnock GL, Dai LJ. Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine. World J Stem Cells 2011; 3(11): 96-103 [PMID: 22180830 DOI: 10.4252/wjsc.v3.i11.96] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v3/i11/96.htm |
| Number | Citing Articles |
| 1 |
Mao-fa Zheng, Si-yu Shen, Wei-da Huang. DCA increases the antitumor effects of capecitabine in a mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft. Cancer Chemotherapy and Pharmacology 2013; 72(5): 1031 doi: 10.1007/s00280-013-2281-z
|
| 2 |
F. Mulas, L. Zagar, B. Zupan, R. Bellazzi. Supporting Regenerative Medicine by Integrative Dimensionality Reduction. Methods of Information in Medicine 2012; 51(04): 341 doi: 10.3414/ME11-02-0045
|
| 3 |
Cho-Won Kim, Hong Kyu Lee, Min-Woo Nam, Gabsang Lee, Kyung-Chul Choi. The Role of <i>KiSS1</i> Gene on the Tumor Growth and Migration of Prostate Cancer and the Underlying Molecular Mechanisms. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4153272
|
| 4 |
Byung Woo Hwang, Su Jin Kim, Kyeng Min Park, Hyemin Kim, Junseok Yeom, Jeong-A Yang, Hyeonseon Jeong, Hyuntae Jung, Kimoon Kim, Young Chul Sung, Sei Kwang Hahn. Genetically engineered mesenchymal stem cell therapy using self-assembling supramolecular hydrogels. Journal of Controlled Release 2015; 220: 119 doi: 10.1016/j.jconrel.2015.10.034
|
| 5 |
M R Moniri, X-Y Sun, J Rayat, D Dai, Z Ao, Z He, C B Verchere, L-J Dai, G L Warnock. TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells. Cancer Gene Therapy 2012; 19(9): 652 doi: 10.1038/cgt.2012.46
|
| 6 |
Razieh Heidari, Neda Gholamian Dehkordi, Roohollah Mohseni, Mohsen Safaei. Engineering mesenchymal stem cells: a novel therapeutic approach in breast cancer. Journal of Drug Targeting 2020; 28(7-8): 732 doi: 10.1080/1061186X.2020.1775842
|
| 7 |
Cho-Won Kim, Hong Kyu Lee, Min-Woo Nam, Gabsang Lee, Kyung-Chul Choi. The role of KiSS1 gene on the growth and migration of prostate cancer and the underlying molecular mechanisms. Life Sciences 2022; 310: 121009 doi: 10.1016/j.lfs.2022.121009
|
| 8 |
Wen'E Cai, Xiaoyu Chen, Qingdong Pan, Shijun Zhang, Luojiao Tan, Xuyong Sun, Renbin Huang, Aijun Xia. Antitumor activity of yulangsan polysacchrides in mice bearing S180 sarcoma tumors. Molecular and Clinical Oncology 2017; 7(4): 716 doi: 10.3892/mco.2017.1378
|
| 9 |
Nedime Serakinci, Pinar Tulay, Rasime Kalkan. Stem Cells: Biology and Engineering. Advances in Experimental Medicine and Biology 2017; 1083: 45 doi: 10.1007/5584_2017_64
|
| 10 |
Xing-Rong Guo, Zhuo-Shun Yang, Xiang-Jun Tang, Dan-Dan Zou, Hui Gui, Xiao-Li Wang, Shi-Nan Ma, Ya-Hong Yuan, Juan Fang, Bin Wang, Li Zhang, Xu-Yong Sun, Garth L. Warnock, Long-Jun Dai, Han-Jun Tu. The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells. Oncotarget 2016; 7(34): 55529 doi: 10.18632/oncotarget.10835
|
| 11 |
Marika Zurmukhtashvili, Avtandil Machavariani, Giorgi Dugashvili, Teimuraz Grdzelidze, Ketevan Gogilashvili, Giorgi Menabde, Ivane Abiatari, Luc Marks. Mesenchymal stem cell transplantation attenuates growth of chemotherapy treated oral squamous cell carcinoma in an animal model. Journal of Oral Pathology & Medicine 2020; 49(7): 655 doi: 10.1111/jop.13006
|
| 12 |
Amir Allahverdi, Ehsan Arefian, Masoud Soleimani, Jafar Ai, Negin Nahanmoghaddam, Aliakbar Yousefi‐Ahmadipour, Somayeh Ebrahimi‐Barough. MicroRNA‐4731‐5p delivered by AD‐mesenchymal stem cells induces cell cycle arrest and apoptosis in glioblastoma. Journal of Cellular Physiology 2020; 235(11): 8167 doi: 10.1002/jcp.29472
|
| 13 |
Xu-Yong Sun, Zhuang Chen, Mani R. Moniri, Hong Lu, Long-Jun Dai, Garth L. Warnock. Anticancer Gene-engineered MSC-mediated Cancer Cell Death: An Imaging Demonstration. Engineering 2012; 4(10): 35 doi: 10.4236/eng.2012.410B009
|
| 14 |
Atsunobu Sagara, Takeshi Karasawa, Katsuhide Igarashi, Maky Otsuka, Rei Sugiura, Akihiro Kodama, Mutsumi Yamashita, Minoru Narita, Yoshinori Kato. Controlled Secretion of the Anticancer Protein MDA-7 from Engineered Mesenchymal Stem Cells. Biological & Pharmaceutical Bulletin 2017; 40(1): 113 doi: 10.1248/bpb.b16-00658
|
| 15 |
Mansoureh Mirabdollahi, Shaghayegh Haghjooy Javanmard, Hojjat Sadeghi-Aliabadi. In Vitro Assessment of Cytokine Expression Profile of MCF-7 Cells inResponse to hWJ-MSCs Secretome. Advanced Pharmaceutical Bulletin 2019; 9(4): 649 doi: 10.15171/apb.2019.075
|
| 16 |
Martin Stimpfel, Thomas Skutella, Branko Cvjeticanin, Marija Meznaric, Peter Dovc, Srdjan Novakovic, Petra Cerkovnik, Eda Vrtacnik-Bokal, Irma Virant-Klun. Isolation, characterization and differentiation of cells expressing pluripotent/multipotent markers from adult human ovaries. Cell and Tissue Research 2013; 354(2): 593 doi: 10.1007/s00441-013-1677-8
|
| 17 |
S. Sharif, M. H. Ghahremani, M. Soleimani. Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton’s Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity. Stem Cell Reviews and Reports 2018; 14(2): 236 doi: 10.1007/s12015-017-9788-3
|
| 18 |
Osama M. Ahmed, Noha A. Ahmed, Nour Y. S. Yassin, Eman R. Abd Elhaliem. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022; : 1089 doi: 10.1007/978-981-16-5422-0_54
|
| 19 |
Jie Luo, Xing‐Rong Guo, Xiang‐Jun Tang, Xu‐Yong Sun, Zhuo‐Shun Yang, Yong Zhang, Long‐Jun Dai, Garth L. Warnock. Intravital biobank and personalized cancer therapy: The correlation with omics. International Journal of Cancer 2014; 135(7): 1511 doi: 10.1002/ijc.28632
|
| 20 |
Osama M. Ahmed, Noha A. Ahmed, Nour Y. S. Yassin, Eman R. Abd Elhaliem. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022; : 1 doi: 10.1007/978-981-16-1247-3_54-1
|
| 21 |
Forough Shams, Bahareh Pourjabbar, Nader Hashemi, Navid Farahmandian, Ali Golchin, Ghader Nuoroozi, Azam Rahimpour. Current progress in engineered and nano-engineered mesenchymal stem cells for cancer: From mechanisms to therapy. Biomedicine & Pharmacotherapy 2023; 167: 115505 doi: 10.1016/j.biopha.2023.115505
|
| 22 |
Kamal Shaik Fakiruddin, Puteri Baharuddin, Moon Nian Lim, Noor Atiqah Fakharuzi, Nurul Ain Nasim M Yusof, Zubaidah Zakaria. Nucleofection optimization and in vitro anti-tumourigenic effect of TRAIL-expressing human adipose-derived mesenchymal stromal cells. Cancer Cell International 2014; 14(1) doi: 10.1186/s12935-014-0122-8
|
| 23 |
Xiangjun Tang, Hao Peng, Pengfei Xu, Li Zhang, Rui Fu, Hanjun Tu, Xingrong Guo, Kuanming Huang, Junti Lu, Hu Chen, Zhiqiang Dong, Longjun Dai, Jie Luo, Qianxue Chen. Synthetic mRNA-based gene therapy for glioblastoma: TRAIL-mRNA synergistically enhances PTEN-mRNA-based therapy. Molecular Therapy - Oncolytics 2022; 24: 707 doi: 10.1016/j.omto.2022.01.013
|
| 24 |
Fengqi Yan, Xia Li, Nan Li, Rui Zhang, Qinhao Wang, Yi Ru, Xiaoke Hao, Jianxin Ni, He Wang, Guojun Wu. Immunoproapoptotic molecule scFv-Fdt-tBid modified mesenchymal stem cells for prostate cancer dual-targeted therapy. Cancer Letters 2017; 402: 32 doi: 10.1016/j.canlet.2017.05.003
|
| 25 |
Long-Jun Dai, Xu-Yong Sun, Jie Luo, Garth L. Warnock. Emerging Trends in Cell and Gene Therapy. 2013; : 271 doi: 10.1007/978-1-62703-417-3_12
|
| 26 |
Seyed-Mahmood Seyed-Khorrami, Hoorieh Soleimanjahi, Sara Soudi, Ala Habibian. MSCs loaded with oncolytic reovirus: migration and in vivo virus delivery potential for evaluating anti-cancer effect in tumor-bearing C57BL/6 mice. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01848-5
|
| 27 |
XING RONG GUO, QIN YONG HU, YA HONG YUAN, XIANG JUN TANG, ZHUO SHUN YANG, DAN DAN ZOU, LIU JIAO BIAN, LONG JUN DAI, DONG SHENG LI. PTEN-mRNA engineered mesenchymal stem cell-mediated cytotoxic effects on U251 glioma cells. Oncology Letters 2016; 11(4): 2733 doi: 10.3892/ol.2016.4297
|
| 28 |
Mozhgan Dehghan Harati, Fatemeh Amiri, Fatemeh Jaleh, Ahmad Mehdipour, Mitra Dehghan Harati, Sedigheh Molaee, Marzieh Bahadori, Mohammad Ali Shokrgozar, Mohammad Ali Jalili, Mehryar Habibi Roudkenar. Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon cancer in order to inhibit liver metastasis in nude mice. Tumor Biology 2015; 36(8): 6011 doi: 10.1007/s13277-015-3277-6
|
| 29 |
Quynh‐Anh NguyenThai, Neelesh Sharma, Do Huynh Luong, Simrinder Singh Sodhi, Jeong‐Hyun Kim, Nameun Kim, Sung‐Jong Oh, Dong Kee Jeong. Targeted inhibition of osteosarcoma tumor growth by bone marrow‐derived mesenchymal stem cells expressing cytosine deaminase/5‐fluorocytosine in tumor‐bearing mice. The Journal of Gene Medicine 2015; 17(3-5): 87 doi: 10.1002/jgm.2826
|
| 30 |
Wahyu Widowati, Harry Murti, Diana Krisanti Jasaputra, Sutiman B. Sumitro, M. Aris Widodo, Nurul Fauziah, Maesaroh Maesaroh, Indra Bachtiar. Selective Cytotoxic Potential of IFN-γ and TNF-α on Breast Cancer Cell Lines (T47D and MCF7). Asian Journal of Cell Biology 2015; 11(1): 1 doi: 10.3923/ajcb.2016.1.12
|
| 31 |
Susan M. Millard, Nicholas M. Fisk. Mesenchymal stem cells for systemic therapy: Shotgun approach or magic bullets?. BioEssays 2013; 35(3): 173 doi: 10.1002/bies.201200087
|
| 32 |
Somayeh Shahrokhi, Saeed Daneshmandi, Farid Menaa. Tumor Necrosis Factor-α/CD40 Ligand-Engineered Mesenchymal Stem Cells Greatly Enhanced the Antitumor Immune Response and Lifespan in Mice. Human Gene Therapy 2014; 25(3): 240 doi: 10.1089/hum.2013.193
|
| 33 |
Guillaume Collet, Catherine Grillon, Mahdi Nadim, Claudine Kieda. Trojan horse at cellular level for tumor gene therapies. Gene 2013; 525(2): 208 doi: 10.1016/j.gene.2013.03.057
|
| 34 |
Fatemeh Hendijani. Human mesenchymal stromal cell therapy for prevention and recovery of chemo/radiotherapy adverse reactions. Cytotherapy 2015; 17(5): 509 doi: 10.1016/j.jcyt.2014.10.015
|
| 35 |
Liyang Zhang, Juanjuan Xiang, Guiyuan Li. The uncertain role of unmodified mesenchymal stem cells in tumor progression: what master switch?. Stem Cell Research & Therapy 2013; 4(2) doi: 10.1186/scrt170
|
| 36 |
Tsai-Hua Chung, Chia-Chu Hsieh, Jong-Kai Hsiao, Szu-Chun Hsu, Ming Yao, Dong-Ming Huang. Dextran-coated iron oxide nanoparticles turn protumor mesenchymal stem cells (MSCs) into antitumor MSCs. RSC Advances 2016; 6(51): 45553 doi: 10.1039/C6RA03453E
|